BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33650657)

  • 21. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
    Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
    Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway.
    Tao L; Chen X; Zheng Y; Wu Y; Jiang X; You M; Li S; Hu F
    Molecules; 2021 May; 26(9):. PubMed ID: 34068565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.
    Wu X; Tang W; Marquez RT; Li K; Highfill CA; He F; Lian J; Lin J; Fuchs JR; Ji M; Li L; Xu L
    Oncotarget; 2016 Mar; 7(10):11708-23. PubMed ID: 26887043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
    Gopal U; Mowery Y; Young K; Pizzo SV
    J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine.
    Zhou L; Wang Q; Zhang H; Li Y; Xie S; Xu M
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31627466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
    Guo Q; Qin W
    J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
    Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
    BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell.
    Li X; Zhao X; Song W; Tian Z; Yang L; Niu Q; Zhang Q; Xie M; Zhou B; Xu Y; Wu J; Zhang C
    Yonsei Med J; 2018 Jan; 59(1):20-27. PubMed ID: 29214772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
    Hu W; Liu Q; Pan J; Sui Z
    Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
    Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG
    Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of ATF-2 enhances epithelial-mesenchymal transition and gemcitabine sensitivity in human pancreatic cancer cells.
    Wu X; Liu Z; Guo K; Ma G; Song S
    J Cell Biochem; 2019 Mar; 120(3):4463-4471. PubMed ID: 30367508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A.
    Xu D; Zhou Y; Xie X; He L; Ding J; Pang S; Shen B; Zhou C
    Int J Oncol; 2020 Nov; 57(5):1223-1233. PubMed ID: 32901837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effect of the herbal mixture C5E on gemcitabine treatment in PANC‑1 cells.
    Pak PJ; Lee DG; Sung JH; Jung SH; Han TY; Park SH; Chung N
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 39. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
    Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.
    Yu L; Chen M; Zhang R; Jin Z
    J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.